"Amodiaquine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A 4-aminoquinoline compound with anti-inflammatory properties.
Concept/Terms
Flavoquine- Flavoquine
- Roussel Brand of Amodiaquine Hydrochloride
Below are MeSH descriptors whose meaning is more general than "Amodiaquine".
Below are MeSH descriptors whose meaning is more specific than "Amodiaquine".
This graph shows the total number of publications written about "Amodiaquine" by people in Harvard Catalyst Profiles by year, and whether "Amodiaquine" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 1 | 1 |
1997 | 1 | 0 | 1 |
1999 | 0 | 1 | 1 |
2004 | 0 | 1 | 1 |
2006 | 2 | 0 | 2 |
2007 | 3 | 1 | 4 |
2008 | 6 | 2 | 8 |
2009 | 1 | 1 | 2 |
2010 | 1 | 0 | 1 |
2011 | 6 | 3 | 9 |
2012 | 1 | 1 | 2 |
2013 | 3 | 2 | 5 |
2014 | 1 | 1 | 2 |
2015 | 1 | 1 | 2 |
2016 | 0 | 1 | 1 |
2017 | 3 | 2 | 5 |
2018 | 0 | 2 | 2 |
2019 | 1 | 2 | 3 |
2020 | 0 | 1 | 1 |
2022 | 0 | 1 | 1 |
2023 | 0 | 1 | 1 |
Below are the most recent publications written about "Amodiaquine" by people in Profiles.
-
Design, Implementation, and Coordination of Malaria Therapeutic Efficacy Studies in Nigeria in 2018. Am J Trop Med Hyg. 2023 06 07; 108(6):1115-1121.
-
Effectiveness of antimalarial drug combinations in treating concomitant urogenital schistosomiasis in malaria patients in Lambaréné, Gabon: A non-randomised event-monitoring study. PLoS Negl Trop Dis. 2022 10; 16(10):e0010899.
-
Efficacy and safety of artemisinin-based combination therapy and the implications of Pfkelch13 and Pfcoronin molecular markers in treatment failure in Senegal. Sci Rep. 2020 06 01; 10(1):8907.
-
Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial. Lancet. 2020 04 25; 395(10233):1345-1360.
-
Consequences of restricting antimalarial drugs to rapid diagnostic test-positive febrile children in south-west Nigeria. Trop Med Int Health. 2019 11; 24(11):1291-1300.
-
Clinical illness and outcomes in Nigerian children with persistent early-appearing anaemia following initiation of artemisinin-based combination treatments of uncomplicated falciparum malaria. Parasite. 2019; 26:56.
-
Declining responsiveness of childhood Plasmodium falciparum infections to artemisinin-based combination treatments ten years following deployment as first-line antimalarials in Nigeria. Infect Dis Poverty. 2019 Aug 06; 8(1):69.
-
Nurr1 (NR4A2) regulates Alzheimer's disease-related pathogenesis and cognitive function in the 5XFAD mouse model. Aging Cell. 2019 02; 18(1):e12866.
-
Efficacy of Artemisinin-Based Combination Treatments of Uncomplicated Falciparum Malaria in Under-Five-Year-Old Nigerian Children Ten Years Following Adoption as First-Line Antimalarials. Am J Trop Med Hyg. 2018 09; 99(3):649-664.
-
Factors contributing to anaemia after uncomplicated falciparum malaria in under five year-old Nigerian children ten years following adoption of artemisinin-based combination therapies as first-line antimalarials. BMC Infect Dis. 2017 12 19; 17(1):781.